Phone-Based Postpartum Continuing Care: Smoking Cessation Beginning in Pregnancy

基于电话的产后持续护理:从怀孕开始戒烟

基本信息

项目摘要

DESCRIPTION (provided by applicant): The large majority of women who quit smoking during pregnancy relapse in the first six months postpartum, highlighting a need for effective postpartum continuing care that supports women through the challenging postpartum period when stress is high and motivation to stay quit may decline. Existing relapse prevention interventions (typically delivered during pregnancy) have been found to be of little benefit during the postpartum period, suggesting the need for a more formal continuing care approach. Phone-based protocols for smoking cessation have been widely disseminated and effective because they address the need for flexible access, but are passive and not typically utilized by women in the postpartum period. The proposed pilot study will develop and test a Phone-based Postpartum Continuing Care (PPCC) model that draws from existing evidence-based protocols--the 5 A's and Recovery Management Checkups (RMC)-- shown to be effective with other populations. The experimental PPCC will reinforce the importance of abstinence, relapse prevention, and reduced smoking through proactive re-intervention (i.e., RMC) with the 5 A's at times when postpartum women are more likely to relapse, and provide education and monitoring of the infant's direct and indirect exposure to nicotine through breastfeeding and secondhand smoke. We will evaluate PPCC's effectiveness relative to a passive referral to a 24/7 hotline, which is current standard care.., Approximately one hundred thirty women in their first or second trimester of pregnancy who were nicotine-dependent in the past year, currently smoke, or quit within the past 90 days will be recruited at their first prenatal appointment at the Maryland Women's Center (MWC) in Baltimore, Maryland. All women will receive the clinic's standard of care for smoking cessation--the 5 A's --during pregnancy from their physician. Half will be randomly assigned to an experimental group getting PPCC for 6 months postpartum and half to a control group receiving only a referral to a passive 24/7 state quit line postpartum. It s expected that in the 6 months following childbirth women in the experimental PPCC (relative to those in the control group) will: a) smoke fewer cigarettes, b) smoke fewer days, c) go longer before postpartum relapse, d) have less time between relapse and talking to a health professional about smoking, e) have less time between relapse and resumption of abstinence , f) smoke fewer times while breastfeeding, g) smoke fewer times while in the same room as the infant, and h) reduce their infant's cotinine levels. The aims of this pilot project are to develo PPCC from existing evidence-based approaches, demonstrate the feasibility of implementing the PPCC intervention with at least 80% compliance and at least 80% follow-up at each wave, and evaluate the effect size associated with receiving standard care vs. standard care + PPCC in order to understand the promise of and appropriate power required for a larger clinical trial.
描述(由申请人提供):绝大多数在怀孕期间戒烟的女性在产后前六个月会复发,这凸显了需要有效的产后持续护理,以支持女性度过充满挑战的产后期,此时压力很大,保持戒烟的动力可能会下降。已经发现现有的复发预防干预措施(通常在怀孕期间提供)在怀孕期间几乎没有益处。 产后期间,这表明需要一个更正式的持续护理的方法。基于电话的戒烟协议已得到广泛传播且有效,因为它们满足了灵活访问的需求,但是被动的,通常不被产后妇女使用。 拟议的试点研究将开发和测试一种基于电话的产后持续护理(PPCC)模型,该模型借鉴了现有的循证协议-5A和恢复管理检查(RMC)-对其他人群有效。实验性PPCC将通过积极主动的再干预(即,RMC)与5A的时候,产后妇女更有可能复发,并提供教育和监测婴儿的直接和间接接触尼古丁通过母乳喂养和二手烟。我们将评估PPCC相对于被动转介到24/7热线的有效性,这是目前的标准护理。大约130名在过去一年中依赖尼古丁、目前吸烟或在过去90天内戒烟的怀孕前三个月或中期的妇女将在第一次产前预约时被招募, 位于马里兰州巴尔的摩的马里兰州妇女中心。所有的妇女在怀孕期间都将从她们的医生那里得到诊所的戒烟护理标准--5A。一半将被随机分配到产后6个月接受PPCC的实验组,另一半将被随机分配到产后仅接受被动24/7状态戒烟热线的对照组。预计在分娩后的6个月内,实验性PPCC中的妇女(相对于对照组)将:a)吸烟更少,B)吸烟天数更少,c)产后复发前的时间更长,d)复发和与健康专业人员谈论吸烟之间的时间更短,e)复发和恢复戒烟之间的时间更短,f)母乳喂养时吸烟次数更少,g)与婴儿在同一个房间时少吸烟,h)降低婴儿的可替宁水平。 该试点项目的目的是从现有的循证方法中发展PPCC,证明实施PPCC干预的可行性,每个波至少有80%的依从性和至少80%的随访,并评估与接受标准治疗与标准治疗+ PPCC相关的效应量,以了解更大规模临床试验的承诺和所需的适当把握度。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Victoria Hope Coleman-Cowger其他文献

Victoria Hope Coleman-Cowger的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Victoria Hope Coleman-Cowger', 18)}}的其他基金

Sickle Cell Disease Cure Initiative (SCDC)
镰状细胞病治愈计划 (SCDC)
  • 批准号:
    9564481
  • 财政年份:
    2017
  • 资助金额:
    $ 20.12万
  • 项目类别:
Sickle Cell Disease Cure Initiative (SCDC)
镰状细胞病治愈计划 (SCDC)
  • 批准号:
    10700477
  • 财政年份:
    2017
  • 资助金额:
    $ 20.12万
  • 项目类别:
Sickle Cell Disease Cure Initiative (SCDC)
镰状细胞病治愈计划 (SCDC)
  • 批准号:
    10469101
  • 财政年份:
    2017
  • 资助金额:
    $ 20.12万
  • 项目类别:
Sickle Cell Disease Cure Initiative (SCDC)
镰状细胞病治愈计划 (SCDC)
  • 批准号:
    10931959
  • 财政年份:
    2017
  • 资助金额:
    $ 20.12万
  • 项目类别:
Comparison of Substance Use Screeners in Assessing Prescription Drug Abuse and Other Illicit Drug Use among Pregnant Women
药物使用筛查仪在评估孕妇处方药滥用和其他非法药物使用方面的比较
  • 批准号:
    9193487
  • 财政年份:
    2016
  • 资助金额:
    $ 20.12万
  • 项目类别:
Comparison of Substance Use Screeners in Assessing Prescription Drug Abuse and Other Illicit Drug Use among Pregnant Women
药物使用筛查仪在评估孕妇处方药滥用和其他非法药物使用方面的比较
  • 批准号:
    9350269
  • 财政年份:
    2016
  • 资助金额:
    $ 20.12万
  • 项目类别:
Comparison of Substance Use Screeners in Assessing Prescription Drug Abuse and Other Illicit Drug Use among Pregnant Women
药物使用筛查仪在评估孕妇处方药滥用和其他非法药物使用方面的比较
  • 批准号:
    9762358
  • 财政年份:
    2016
  • 资助金额:
    $ 20.12万
  • 项目类别:
Phone-Based Postpartum Continuing Care: Smoking Cessation Beginning in Pregnancy
基于电话的产后持续护理:从怀孕开始戒烟
  • 批准号:
    8386735
  • 财政年份:
    2012
  • 资助金额:
    $ 20.12万
  • 项目类别:
Phone-Based Postpartum Continuing Care: Smoking Cessation Beginning in Pregnancy
基于电话的产后持续护理:从怀孕开始戒烟
  • 批准号:
    8884766
  • 财政年份:
    2012
  • 资助金额:
    $ 20.12万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 20.12万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 20.12万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.12万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.12万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 20.12万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.12万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 20.12万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 20.12万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 20.12万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.12万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了